Donald R. Hurd, age 62, is Chief Commercial Officer and Senior Vice President, a position he has held since May 2012. He brings over 30 years of experience in the medical diagnostic and device industry, having worked in both large diagnostic companies and start-ups.
Prior to joining Riot, Mr. Hurd served as Vice President of Sales at BioBehavorial Diagnostics from July 2010 to March 2012. His earlier roles include Vice President of Marketing/Sales at MicroPhage, Vice President of North American Customer Operations at Siemens Healthcare Diagnostics, and U.S. Director of Sales at Bayer Healthcare Diagnostics.
Mr. Hurd holds a B.S. in business administration and is a military veteran of the United States Navy.
Biography extracted from Riot DEF 14A filed 2014-04-30 View cached copy (2026-09-27)Live source ↗
Roles
Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.
| Company | Role | Tenure | Filings |
|---|---|---|---|
| Riot | SVP, Chief Commerical Officer | 2012-05 → present (14y 6mo) | 6 |
Show 6 underlying filings | |||
| Riot | SVP & Chief Commercial Officer | 2014-04 → present (12y 7mo) | 2 |
Show 2 underlying filings | |||
Insider transactions
Totals for this person
| Bucket | Invested (shares) | Invested (USD) | Divested (shares) | Divested (USD) | Net direction | Txns | Invested @ last price | Divested @ last price |
|---|---|---|---|---|---|---|---|---|
| All time | 428,000 | $101.1K | - | $0 | ↑ Invested $101.1K | 8 | $5.48M | $0 |
| 2015 | 50,000 | $0 | - | $0 | Flat | 1 | $640.5K | $0 |
| 2014 | 124,000 | $71.3K | - | $0 | ↑ Invested $71.3K | 2 | $1.59M | $0 |
| 2013 | 69,000 | $0 | - | $0 | Flat | 1 | $883.9K | $0 |
| 2013-Q1 | 69,000 | $0 | - | $0 | Flat | 1 | $883.9K | $0 |
| 2014-Q1 | 89,000 | $0 | - | $0 | Flat | 1 | $1.14M | $0 |
| 2014-Q2 | 35,000 | $71.3K | - | $0 | ↑ Invested $71.3K | 1 | $448.4K | $0 |
| 2015-Q1 | 50,000 | $0 | - | $0 | Flat | 1 | $640.5K | $0 |
Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-10-30); they are a valuation, not a cash flow, and they move every day the market does.
All transactions
| Date | Company | Kind | Shares | Amount (USD) | Value @ last price |
|---|---|---|---|---|---|
| 2015-01-12 | Riot | Grant / award / vesting · Stock Option (Right to Buy) | 50,000 | - | $640.5K |
| 2014-04-14 | Riot | Open-market purchase | 35,000 | $71,260 | $448.4K |
| 2014-01-06 | Riot | Grant / award / vesting · Stock Option (Right to Buy) | 89,000 | - | $1.14M |
| 2013-01-23 | Riot | Grant / award / vesting · Stock Option (Right to Buy) | 69,000 | - | $883.9K |
| 2012-12-11 | Riot | Grant / award / vesting · Stock Option (Right to Buy) | 40,000 | - | $512.4K |
| 2012-09-21 | Riot | Open-market purchase | 15,000 | $29,850 | $192.2K |
| 2012-09-19 | Riot | Grant / award / vesting · Stock Option (Right to Buy) | 10,000 | - | $128.1K |
| 2012-05-23 | Riot | Grant / award / vesting · Stock Option (Right to Buy) | 120,000 | - | $1.54M |